A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
"In Physically Active Patients Predisposed to Bone- Muscle Attrition Receiving Androgen Deprivation Therapy for Prostate Cancer Treatment, Prospective MRI Evaluation Does Not Demonstrate Significant Muscle Alteration"
2021
Biomedical Journal of Scientific & Technical Research
Introduction The Global Cancer Observatory identified Prostate Cancer as the 2 nd most commonly diagnosed cancer and 5th most deadly in men worldwide [1] . Androgens are important for the growth of the prostate gland, and men with elevated testosterone levels are shown to have an increased risk for developing prostate cancer [2] . Androgen deprivation therapy (ADT) has been used as a standard of care treatment for prostate cancer amelioration and it has shown to reduce adult prostatic
doi:10.26717/bjstr.2021.37.005981
fatcat:vk7auauqubb5vfwsp6enb5eviu